nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoricoxib—CYP2D6—breast cancer	0.109	0.371	CbGaD
Etoricoxib—CYP3A4—breast cancer	0.0937	0.318	CbGaD
Etoricoxib—PTGS2—breast cancer	0.0918	0.311	CbGaD
Etoricoxib—CYP1A2—Anastrozole—breast cancer	0.027	0.0707	CbGbCtD
Etoricoxib—CYP1A2—Toremifene—breast cancer	0.0247	0.0646	CbGbCtD
Etoricoxib—CYP2C9—Anastrozole—breast cancer	0.0243	0.0637	CbGbCtD
Etoricoxib—CYP2C19—Lapatinib—breast cancer	0.0195	0.0511	CbGbCtD
Etoricoxib—CYP3A4—Exemestane—breast cancer	0.0187	0.0488	CbGbCtD
Etoricoxib—CYP2C9—Idarubicin—breast cancer	0.0184	0.0482	CbGbCtD
Etoricoxib—CYP2D6—Idarubicin—breast cancer	0.0169	0.0441	CbGbCtD
Etoricoxib—CYP3A4—Letrozole—breast cancer	0.0159	0.0415	CbGbCtD
Etoricoxib—CYP2E1—Tamoxifen—breast cancer	0.0156	0.0408	CbGbCtD
Etoricoxib—CYP2E1—Mitoxantrone—breast cancer	0.0152	0.0398	CbGbCtD
Etoricoxib—CYP3A4—Anastrozole—breast cancer	0.0141	0.037	CbGbCtD
Etoricoxib—CYP3A4—Toremifene—breast cancer	0.0129	0.0339	CbGbCtD
Etoricoxib—CYP3A4—Fulvestrant—breast cancer	0.012	0.0315	CbGbCtD
Etoricoxib—CYP3A4—Thiotepa—breast cancer	0.0107	0.0281	CbGbCtD
Etoricoxib—CYP2C9—Capecitabine—breast cancer	0.0101	0.0264	CbGbCtD
Etoricoxib—CYP3A4—Ixabepilone—breast cancer	0.0098	0.0257	CbGbCtD
Etoricoxib—CYP2C19—Tamoxifen—breast cancer	0.00977	0.0256	CbGbCtD
Etoricoxib—CYP3A4—Lapatinib—breast cancer	0.00943	0.0247	CbGbCtD
Etoricoxib—CYP1A2—Tamoxifen—breast cancer	0.00902	0.0236	CbGbCtD
Etoricoxib—CYP2D6—Vinorelbine—breast cancer	0.00823	0.0215	CbGbCtD
Etoricoxib—CYP2C9—Tamoxifen—breast cancer	0.00812	0.0213	CbGbCtD
Etoricoxib—CYP2D6—Tamoxifen—breast cancer	0.00743	0.0194	CbGbCtD
Etoricoxib—CYP3A4—Raloxifene—breast cancer	0.00715	0.0187	CbGbCtD
Etoricoxib—CYP1A2—Fluorouracil—breast cancer	0.00664	0.0174	CbGbCtD
Etoricoxib—CYP2C9—Paclitaxel—breast cancer	0.00632	0.0166	CbGbCtD
Etoricoxib—CYP2C9—Fluorouracil—breast cancer	0.00599	0.0157	CbGbCtD
Etoricoxib—CYP3A4—Vinorelbine—breast cancer	0.00523	0.0137	CbGbCtD
Etoricoxib—CYP2D6—Vinblastine—breast cancer	0.00507	0.0133	CbGbCtD
Etoricoxib—CYP3A4—Tamoxifen—breast cancer	0.00472	0.0124	CbGbCtD
Etoricoxib—CYP3A4—Mitoxantrone—breast cancer	0.00461	0.0121	CbGbCtD
Etoricoxib—CYP3A4—Paclitaxel—breast cancer	0.00368	0.00963	CbGbCtD
Etoricoxib—CYP3A4—Irinotecan—breast cancer	0.00363	0.0095	CbGbCtD
Etoricoxib—CYP3A4—Vinblastine—breast cancer	0.00322	0.00844	CbGbCtD
Etoricoxib—CYP2D6—Doxorubicin—breast cancer	0.00312	0.00816	CbGbCtD
Etoricoxib—CYP3A4—Docetaxel—breast cancer	0.00266	0.00696	CbGbCtD
Etoricoxib—CYP3A4—Doxorubicin—breast cancer	0.00198	0.00519	CbGbCtD
Etoricoxib—Vemurafenib—RAF1—breast cancer	0.00136	0.244	CrCbGaD
Etoricoxib—MAPK14—embryo—breast cancer	0.00112	0.0762	CbGeAlD
Etoricoxib—Vemurafenib—BRAF—breast cancer	0.000943	0.169	CrCbGaD
Etoricoxib—MAPK14—epithelium—breast cancer	0.000918	0.0622	CbGeAlD
Etoricoxib—MAPK14—skin of body—breast cancer	0.000873	0.0592	CbGeAlD
Etoricoxib—Vemurafenib—ABCC1—breast cancer	0.000794	0.143	CrCbGaD
Etoricoxib—MAPK14—uterus—breast cancer	0.000758	0.0514	CbGeAlD
Etoricoxib—MAPK14—pituitary gland—breast cancer	0.000745	0.0505	CbGeAlD
Etoricoxib—MAPK14—adipose tissue—breast cancer	0.000742	0.0503	CbGeAlD
Etoricoxib—MAPK14—female reproductive system—breast cancer	0.000682	0.0462	CbGeAlD
Etoricoxib—MAPK14—adrenal gland—breast cancer	0.000665	0.0451	CbGeAlD
Etoricoxib—MAPK14—bone marrow—breast cancer	0.000644	0.0436	CbGeAlD
Etoricoxib—MAPK14—female gonad—breast cancer	0.00062	0.042	CbGeAlD
Etoricoxib—MAPK14—endocrine gland—breast cancer	0.000577	0.0391	CbGeAlD
Etoricoxib—CYP2C9—mammary gland—breast cancer	0.000543	0.0368	CbGeAlD
Etoricoxib—CYP1A2—nipple—breast cancer	0.000473	0.0321	CbGeAlD
Etoricoxib—Celecoxib—CA9—breast cancer	0.000427	0.0767	CrCbGaD
Etoricoxib—Vemurafenib—ABCG2—breast cancer	0.000419	0.0752	CrCbGaD
Etoricoxib—MAPK14—lymph node—breast cancer	0.000399	0.027	CbGeAlD
Etoricoxib—PTGS2—embryo—breast cancer	0.000323	0.0219	CbGeAlD
Etoricoxib—PTGS2—epithelium—breast cancer	0.000264	0.0179	CbGeAlD
Etoricoxib—PTGS2—skin of body—breast cancer	0.000251	0.017	CbGeAlD
Etoricoxib—CYP2C19—endocrine gland—breast cancer	0.000245	0.0166	CbGeAlD
Etoricoxib—Vemurafenib—CYP2D6—breast cancer	0.000244	0.0438	CrCbGaD
Etoricoxib—PTGS2—endometrium—breast cancer	0.000237	0.016	CbGeAlD
Etoricoxib—CYP2C9—female reproductive system—breast cancer	0.000225	0.0152	CbGeAlD
Etoricoxib—PTGS2—uterus—breast cancer	0.000218	0.0148	CbGeAlD
Etoricoxib—PTGS2—pituitary gland—breast cancer	0.000214	0.0145	CbGeAlD
Etoricoxib—PTGS2—adipose tissue—breast cancer	0.000213	0.0145	CbGeAlD
Etoricoxib—CYP2E1—female reproductive system—breast cancer	0.000213	0.0144	CbGeAlD
Etoricoxib—Vismodegib—ABCG2—breast cancer	0.000211	0.0379	CrCbGaD
Etoricoxib—Vemurafenib—CYP3A4—breast cancer	0.000209	0.0376	CrCbGaD
Etoricoxib—CYP2E1—adrenal gland—breast cancer	0.000208	0.0141	CbGeAlD
Etoricoxib—CYP1A2—endocrine gland—breast cancer	0.0002	0.0136	CbGeAlD
Etoricoxib—PTGS2—female reproductive system—breast cancer	0.000196	0.0133	CbGeAlD
Etoricoxib—PTGS2—adrenal gland—breast cancer	0.000191	0.013	CbGeAlD
Etoricoxib—CYP2C9—endocrine gland—breast cancer	0.00019	0.0129	CbGeAlD
Etoricoxib—PTGS2—bone marrow—breast cancer	0.000185	0.0125	CbGeAlD
Etoricoxib—Vemurafenib—ALB—breast cancer	0.000183	0.0328	CrCbGaD
Etoricoxib—CYP2E1—endocrine gland—breast cancer	0.00018	0.0122	CbGeAlD
Etoricoxib—PTGS2—female gonad—breast cancer	0.000178	0.0121	CbGeAlD
Etoricoxib—CYP3A4—female reproductive system—breast cancer	0.000171	0.0116	CbGeAlD
Etoricoxib—CYP2D6—female reproductive system—breast cancer	0.000169	0.0114	CbGeAlD
Etoricoxib—PTGS2—endocrine gland—breast cancer	0.000166	0.0112	CbGeAlD
Etoricoxib—CYP2D6—female gonad—breast cancer	0.000153	0.0104	CbGeAlD
Etoricoxib—CYP3A4—endocrine gland—breast cancer	0.000145	0.00983	CbGeAlD
Etoricoxib—Celecoxib—CYP2D6—breast cancer	0.000143	0.0258	CrCbGaD
Etoricoxib—CYP2D6—endocrine gland—breast cancer	0.000143	0.00967	CbGeAlD
Etoricoxib—Celecoxib—CYP3A4—breast cancer	0.000123	0.0221	CrCbGaD
Etoricoxib—Celecoxib—PTGS2—breast cancer	0.00012	0.0216	CrCbGaD
Etoricoxib—PTGS2—lymph node—breast cancer	0.000115	0.00777	CbGeAlD
Etoricoxib—Celecoxib—ALB—breast cancer	0.000107	0.0193	CrCbGaD
Etoricoxib—Vismodegib—CYP3A4—breast cancer	0.000105	0.0189	CrCbGaD
Etoricoxib—Vismodegib—ALB—breast cancer	9.2e-05	0.0165	CrCbGaD
Etoricoxib—Vismodegib—ABCB1—breast cancer	8.78e-05	0.0158	CrCbGaD
Etoricoxib—Sinusitis—Doxorubicin—breast cancer	2.8e-05	0.000158	CcSEcCtD
Etoricoxib—Immune system disorder—Methotrexate—breast cancer	2.79e-05	0.000158	CcSEcCtD
Etoricoxib—Dizziness—Fluorouracil—breast cancer	2.79e-05	0.000158	CcSEcCtD
Etoricoxib—Visual impairment—Epirubicin—breast cancer	2.79e-05	0.000157	CcSEcCtD
Etoricoxib—Mediastinal disorder—Methotrexate—breast cancer	2.79e-05	0.000157	CcSEcCtD
Etoricoxib—Rash—Mitoxantrone—breast cancer	2.78e-05	0.000157	CcSEcCtD
Etoricoxib—Rash—Irinotecan—breast cancer	2.78e-05	0.000157	CcSEcCtD
Etoricoxib—Dermatitis—Irinotecan—breast cancer	2.78e-05	0.000157	CcSEcCtD
Etoricoxib—Dermatitis—Mitoxantrone—breast cancer	2.78e-05	0.000157	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Docetaxel—breast cancer	2.78e-05	0.000157	CcSEcCtD
Etoricoxib—Headache—Irinotecan—breast cancer	2.76e-05	0.000156	CcSEcCtD
Etoricoxib—Headache—Mitoxantrone—breast cancer	2.76e-05	0.000156	CcSEcCtD
Etoricoxib—Insomnia—Docetaxel—breast cancer	2.76e-05	0.000156	CcSEcCtD
Etoricoxib—Erythema multiforme—Epirubicin—breast cancer	2.74e-05	0.000154	CcSEcCtD
Etoricoxib—Alopecia—Methotrexate—breast cancer	2.73e-05	0.000154	CcSEcCtD
Etoricoxib—Vomiting—Gemcitabine—breast cancer	2.73e-05	0.000154	CcSEcCtD
Etoricoxib—Dyspnoea—Docetaxel—breast cancer	2.72e-05	0.000153	CcSEcCtD
Etoricoxib—Somnolence—Docetaxel—breast cancer	2.71e-05	0.000153	CcSEcCtD
Etoricoxib—Mental disorder—Methotrexate—breast cancer	2.71e-05	0.000153	CcSEcCtD
Etoricoxib—Rash—Gemcitabine—breast cancer	2.71e-05	0.000153	CcSEcCtD
Etoricoxib—Dermatitis—Gemcitabine—breast cancer	2.71e-05	0.000153	CcSEcCtD
Etoricoxib—Eye disorder—Epirubicin—breast cancer	2.71e-05	0.000153	CcSEcCtD
Etoricoxib—Tinnitus—Epirubicin—breast cancer	2.7e-05	0.000152	CcSEcCtD
Etoricoxib—Malnutrition—Methotrexate—breast cancer	2.69e-05	0.000152	CcSEcCtD
Etoricoxib—Erythema—Methotrexate—breast cancer	2.69e-05	0.000152	CcSEcCtD
Etoricoxib—Haemoglobin—Doxorubicin—breast cancer	2.69e-05	0.000152	CcSEcCtD
Etoricoxib—Headache—Gemcitabine—breast cancer	2.69e-05	0.000152	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Capecitabine—breast cancer	2.69e-05	0.000152	CcSEcCtD
Etoricoxib—Flushing—Epirubicin—breast cancer	2.69e-05	0.000152	CcSEcCtD
Etoricoxib—Cardiac disorder—Epirubicin—breast cancer	2.69e-05	0.000152	CcSEcCtD
Etoricoxib—Vomiting—Fluorouracil—breast cancer	2.69e-05	0.000152	CcSEcCtD
Etoricoxib—Dyspepsia—Docetaxel—breast cancer	2.68e-05	0.000151	CcSEcCtD
Etoricoxib—Haemorrhage—Doxorubicin—breast cancer	2.68e-05	0.000151	CcSEcCtD
Etoricoxib—Hepatitis—Doxorubicin—breast cancer	2.68e-05	0.000151	CcSEcCtD
Etoricoxib—Insomnia—Capecitabine—breast cancer	2.67e-05	0.000151	CcSEcCtD
Etoricoxib—Hypoaesthesia—Doxorubicin—breast cancer	2.67e-05	0.00015	CcSEcCtD
Etoricoxib—Rash—Fluorouracil—breast cancer	2.66e-05	0.00015	CcSEcCtD
Etoricoxib—Dermatitis—Fluorouracil—breast cancer	2.66e-05	0.00015	CcSEcCtD
Etoricoxib—Pharyngitis—Doxorubicin—breast cancer	2.66e-05	0.00015	CcSEcCtD
Etoricoxib—Decreased appetite—Docetaxel—breast cancer	2.65e-05	0.00015	CcSEcCtD
Etoricoxib—Hypersensitivity—Paclitaxel—breast cancer	2.65e-05	0.00015	CcSEcCtD
Etoricoxib—Headache—Fluorouracil—breast cancer	2.65e-05	0.000149	CcSEcCtD
Etoricoxib—Urinary tract disorder—Doxorubicin—breast cancer	2.65e-05	0.000149	CcSEcCtD
Etoricoxib—Oedema peripheral—Doxorubicin—breast cancer	2.64e-05	0.000149	CcSEcCtD
Etoricoxib—Dysgeusia—Methotrexate—breast cancer	2.64e-05	0.000149	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Docetaxel—breast cancer	2.63e-05	0.000149	CcSEcCtD
Etoricoxib—Connective tissue disorder—Doxorubicin—breast cancer	2.63e-05	0.000148	CcSEcCtD
Etoricoxib—Dyspnoea—Capecitabine—breast cancer	2.63e-05	0.000148	CcSEcCtD
Etoricoxib—Fatigue—Docetaxel—breast cancer	2.63e-05	0.000148	CcSEcCtD
Etoricoxib—Angiopathy—Epirubicin—breast cancer	2.63e-05	0.000148	CcSEcCtD
Etoricoxib—Urethral disorder—Doxorubicin—breast cancer	2.63e-05	0.000148	CcSEcCtD
Etoricoxib—Nausea—Irinotecan—breast cancer	2.62e-05	0.000148	CcSEcCtD
Etoricoxib—Nausea—Mitoxantrone—breast cancer	2.62e-05	0.000148	CcSEcCtD
Etoricoxib—Immune system disorder—Epirubicin—breast cancer	2.62e-05	0.000148	CcSEcCtD
Etoricoxib—Mediastinal disorder—Epirubicin—breast cancer	2.61e-05	0.000147	CcSEcCtD
Etoricoxib—Pain—Docetaxel—breast cancer	2.61e-05	0.000147	CcSEcCtD
Etoricoxib—Constipation—Docetaxel—breast cancer	2.61e-05	0.000147	CcSEcCtD
Etoricoxib—Dyspepsia—Capecitabine—breast cancer	2.6e-05	0.000147	CcSEcCtD
Etoricoxib—Arrhythmia—Epirubicin—breast cancer	2.59e-05	0.000146	CcSEcCtD
Etoricoxib—Visual impairment—Doxorubicin—breast cancer	2.58e-05	0.000146	CcSEcCtD
Etoricoxib—Asthenia—Paclitaxel—breast cancer	2.58e-05	0.000146	CcSEcCtD
Etoricoxib—Decreased appetite—Capecitabine—breast cancer	2.57e-05	0.000145	CcSEcCtD
Etoricoxib—Alopecia—Epirubicin—breast cancer	2.56e-05	0.000144	CcSEcCtD
Etoricoxib—Nausea—Gemcitabine—breast cancer	2.55e-05	0.000144	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Capecitabine—breast cancer	2.55e-05	0.000144	CcSEcCtD
Etoricoxib—Fatigue—Capecitabine—breast cancer	2.55e-05	0.000144	CcSEcCtD
Etoricoxib—Pruritus—Paclitaxel—breast cancer	2.55e-05	0.000144	CcSEcCtD
Etoricoxib—Vision blurred—Methotrexate—breast cancer	2.54e-05	0.000143	CcSEcCtD
Etoricoxib—Mental disorder—Epirubicin—breast cancer	2.54e-05	0.000143	CcSEcCtD
Etoricoxib—Erythema multiforme—Doxorubicin—breast cancer	2.53e-05	0.000143	CcSEcCtD
Etoricoxib—Pain—Capecitabine—breast cancer	2.52e-05	0.000142	CcSEcCtD
Etoricoxib—Constipation—Capecitabine—breast cancer	2.52e-05	0.000142	CcSEcCtD
Etoricoxib—Erythema—Epirubicin—breast cancer	2.52e-05	0.000142	CcSEcCtD
Etoricoxib—Malnutrition—Epirubicin—breast cancer	2.52e-05	0.000142	CcSEcCtD
Etoricoxib—Feeling abnormal—Docetaxel—breast cancer	2.51e-05	0.000142	CcSEcCtD
Etoricoxib—Nausea—Fluorouracil—breast cancer	2.51e-05	0.000142	CcSEcCtD
Etoricoxib—Eye disorder—Doxorubicin—breast cancer	2.5e-05	0.000141	CcSEcCtD
Etoricoxib—Tinnitus—Doxorubicin—breast cancer	2.5e-05	0.000141	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Docetaxel—breast cancer	2.49e-05	0.000141	CcSEcCtD
Etoricoxib—Anaemia—Methotrexate—breast cancer	2.49e-05	0.00014	CcSEcCtD
Etoricoxib—Cardiac disorder—Doxorubicin—breast cancer	2.49e-05	0.00014	CcSEcCtD
Etoricoxib—Flushing—Doxorubicin—breast cancer	2.49e-05	0.00014	CcSEcCtD
Etoricoxib—Flatulence—Epirubicin—breast cancer	2.48e-05	0.00014	CcSEcCtD
Etoricoxib—Dysgeusia—Epirubicin—breast cancer	2.47e-05	0.000139	CcSEcCtD
Etoricoxib—Diarrhoea—Paclitaxel—breast cancer	2.46e-05	0.000139	CcSEcCtD
Etoricoxib—Feeling abnormal—Capecitabine—breast cancer	2.43e-05	0.000137	CcSEcCtD
Etoricoxib—Angiopathy—Doxorubicin—breast cancer	2.43e-05	0.000137	CcSEcCtD
Etoricoxib—Muscle spasms—Epirubicin—breast cancer	2.42e-05	0.000137	CcSEcCtD
Etoricoxib—Immune system disorder—Doxorubicin—breast cancer	2.42e-05	0.000136	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Capecitabine—breast cancer	2.41e-05	0.000136	CcSEcCtD
Etoricoxib—Mediastinal disorder—Doxorubicin—breast cancer	2.41e-05	0.000136	CcSEcCtD
Etoricoxib—Abdominal pain—Docetaxel—breast cancer	2.41e-05	0.000136	CcSEcCtD
Etoricoxib—Arrhythmia—Doxorubicin—breast cancer	2.39e-05	0.000135	CcSEcCtD
Etoricoxib—Dizziness—Paclitaxel—breast cancer	2.38e-05	0.000134	CcSEcCtD
Etoricoxib—Vision blurred—Epirubicin—breast cancer	2.38e-05	0.000134	CcSEcCtD
Etoricoxib—Alopecia—Doxorubicin—breast cancer	2.37e-05	0.000134	CcSEcCtD
Etoricoxib—Cough—Methotrexate—breast cancer	2.35e-05	0.000133	CcSEcCtD
Etoricoxib—Mental disorder—Doxorubicin—breast cancer	2.35e-05	0.000132	CcSEcCtD
Etoricoxib—Urticaria—Capecitabine—breast cancer	2.35e-05	0.000132	CcSEcCtD
Etoricoxib—Abdominal pain—Capecitabine—breast cancer	2.33e-05	0.000132	CcSEcCtD
Etoricoxib—Malnutrition—Doxorubicin—breast cancer	2.33e-05	0.000132	CcSEcCtD
Etoricoxib—Erythema—Doxorubicin—breast cancer	2.33e-05	0.000132	CcSEcCtD
Etoricoxib—Anaemia—Epirubicin—breast cancer	2.33e-05	0.000131	CcSEcCtD
Etoricoxib—Agitation—Epirubicin—breast cancer	2.32e-05	0.000131	CcSEcCtD
Etoricoxib—Flatulence—Doxorubicin—breast cancer	2.3e-05	0.00013	CcSEcCtD
Etoricoxib—Arthralgia—Methotrexate—breast cancer	2.29e-05	0.000129	CcSEcCtD
Etoricoxib—Chest pain—Methotrexate—breast cancer	2.29e-05	0.000129	CcSEcCtD
Etoricoxib—Vomiting—Paclitaxel—breast cancer	2.29e-05	0.000129	CcSEcCtD
Etoricoxib—Dysgeusia—Doxorubicin—breast cancer	2.28e-05	0.000129	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	2.28e-05	0.000128	CcSEcCtD
Etoricoxib—Rash—Paclitaxel—breast cancer	2.27e-05	0.000128	CcSEcCtD
Etoricoxib—Dermatitis—Paclitaxel—breast cancer	2.27e-05	0.000128	CcSEcCtD
Etoricoxib—Headache—Paclitaxel—breast cancer	2.25e-05	0.000127	CcSEcCtD
Etoricoxib—Hypersensitivity—Docetaxel—breast cancer	2.25e-05	0.000127	CcSEcCtD
Etoricoxib—Muscle spasms—Doxorubicin—breast cancer	2.24e-05	0.000126	CcSEcCtD
Etoricoxib—Palpitations—Epirubicin—breast cancer	2.23e-05	0.000126	CcSEcCtD
Etoricoxib—Confusional state—Methotrexate—breast cancer	2.22e-05	0.000125	CcSEcCtD
Etoricoxib—Cough—Epirubicin—breast cancer	2.2e-05	0.000124	CcSEcCtD
Etoricoxib—Anaphylactic shock—Methotrexate—breast cancer	2.2e-05	0.000124	CcSEcCtD
Etoricoxib—Vision blurred—Doxorubicin—breast cancer	2.2e-05	0.000124	CcSEcCtD
Etoricoxib—Asthenia—Docetaxel—breast cancer	2.19e-05	0.000123	CcSEcCtD
Etoricoxib—Infection—Methotrexate—breast cancer	2.18e-05	0.000123	CcSEcCtD
Etoricoxib—Hypertension—Epirubicin—breast cancer	2.18e-05	0.000123	CcSEcCtD
Etoricoxib—Hypersensitivity—Capecitabine—breast cancer	2.18e-05	0.000123	CcSEcCtD
Etoricoxib—Pruritus—Docetaxel—breast cancer	2.16e-05	0.000122	CcSEcCtD
Etoricoxib—Nervous system disorder—Methotrexate—breast cancer	2.16e-05	0.000122	CcSEcCtD
Etoricoxib—Anaemia—Doxorubicin—breast cancer	2.16e-05	0.000122	CcSEcCtD
Etoricoxib—Thrombocytopenia—Methotrexate—breast cancer	2.15e-05	0.000121	CcSEcCtD
Etoricoxib—Arthralgia—Epirubicin—breast cancer	2.15e-05	0.000121	CcSEcCtD
Etoricoxib—Chest pain—Epirubicin—breast cancer	2.15e-05	0.000121	CcSEcCtD
Etoricoxib—Agitation—Doxorubicin—breast cancer	2.14e-05	0.000121	CcSEcCtD
Etoricoxib—Anxiety—Epirubicin—breast cancer	2.14e-05	0.000121	CcSEcCtD
Etoricoxib—Nausea—Paclitaxel—breast cancer	2.14e-05	0.000121	CcSEcCtD
Etoricoxib—Skin disorder—Methotrexate—breast cancer	2.13e-05	0.00012	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	2.13e-05	0.00012	CcSEcCtD
Etoricoxib—Asthenia—Capecitabine—breast cancer	2.12e-05	0.000119	CcSEcCtD
Etoricoxib—Dry mouth—Epirubicin—breast cancer	2.1e-05	0.000118	CcSEcCtD
Etoricoxib—Anorexia—Methotrexate—breast cancer	2.1e-05	0.000118	CcSEcCtD
Etoricoxib—Pruritus—Capecitabine—breast cancer	2.09e-05	0.000118	CcSEcCtD
Etoricoxib—Diarrhoea—Docetaxel—breast cancer	2.09e-05	0.000118	CcSEcCtD
Etoricoxib—Confusional state—Epirubicin—breast cancer	2.07e-05	0.000117	CcSEcCtD
Etoricoxib—Palpitations—Doxorubicin—breast cancer	2.06e-05	0.000116	CcSEcCtD
Etoricoxib—Anaphylactic shock—Epirubicin—breast cancer	2.06e-05	0.000116	CcSEcCtD
Etoricoxib—Oedema—Epirubicin—breast cancer	2.06e-05	0.000116	CcSEcCtD
Etoricoxib—Infection—Epirubicin—breast cancer	2.04e-05	0.000115	CcSEcCtD
Etoricoxib—Cough—Doxorubicin—breast cancer	2.03e-05	0.000115	CcSEcCtD
Etoricoxib—Shock—Epirubicin—breast cancer	2.02e-05	0.000114	CcSEcCtD
Etoricoxib—Diarrhoea—Capecitabine—breast cancer	2.02e-05	0.000114	CcSEcCtD
Etoricoxib—Nervous system disorder—Epirubicin—breast cancer	2.02e-05	0.000114	CcSEcCtD
Etoricoxib—Dizziness—Docetaxel—breast cancer	2.02e-05	0.000114	CcSEcCtD
Etoricoxib—Thrombocytopenia—Epirubicin—breast cancer	2.01e-05	0.000114	CcSEcCtD
Etoricoxib—Hypertension—Doxorubicin—breast cancer	2.01e-05	0.000114	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Methotrexate—breast cancer	2e-05	0.000113	CcSEcCtD
Etoricoxib—Skin disorder—Epirubicin—breast cancer	2e-05	0.000113	CcSEcCtD
Etoricoxib—Insomnia—Methotrexate—breast cancer	1.99e-05	0.000112	CcSEcCtD
Etoricoxib—Chest pain—Doxorubicin—breast cancer	1.99e-05	0.000112	CcSEcCtD
Etoricoxib—Arthralgia—Doxorubicin—breast cancer	1.99e-05	0.000112	CcSEcCtD
Etoricoxib—Anxiety—Doxorubicin—breast cancer	1.98e-05	0.000112	CcSEcCtD
Etoricoxib—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	1.97e-05	0.000111	CcSEcCtD
Etoricoxib—Anorexia—Epirubicin—breast cancer	1.96e-05	0.000111	CcSEcCtD
Etoricoxib—Dyspnoea—Methotrexate—breast cancer	1.96e-05	0.000111	CcSEcCtD
Etoricoxib—Somnolence—Methotrexate—breast cancer	1.95e-05	0.00011	CcSEcCtD
Etoricoxib—Dizziness—Capecitabine—breast cancer	1.95e-05	0.00011	CcSEcCtD
Etoricoxib—Dry mouth—Doxorubicin—breast cancer	1.94e-05	0.00011	CcSEcCtD
Etoricoxib—Vomiting—Docetaxel—breast cancer	1.94e-05	0.000109	CcSEcCtD
Etoricoxib—Dyspepsia—Methotrexate—breast cancer	1.93e-05	0.000109	CcSEcCtD
Etoricoxib—Rash—Docetaxel—breast cancer	1.92e-05	0.000108	CcSEcCtD
Etoricoxib—Dermatitis—Docetaxel—breast cancer	1.92e-05	0.000108	CcSEcCtD
Etoricoxib—Confusional state—Doxorubicin—breast cancer	1.92e-05	0.000108	CcSEcCtD
Etoricoxib—Decreased appetite—Methotrexate—breast cancer	1.91e-05	0.000108	CcSEcCtD
Etoricoxib—Headache—Docetaxel—breast cancer	1.91e-05	0.000108	CcSEcCtD
Etoricoxib—Anaphylactic shock—Doxorubicin—breast cancer	1.9e-05	0.000107	CcSEcCtD
Etoricoxib—Oedema—Doxorubicin—breast cancer	1.9e-05	0.000107	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Methotrexate—breast cancer	1.9e-05	0.000107	CcSEcCtD
Etoricoxib—Fatigue—Methotrexate—breast cancer	1.89e-05	0.000107	CcSEcCtD
Etoricoxib—Infection—Doxorubicin—breast cancer	1.89e-05	0.000107	CcSEcCtD
Etoricoxib—Pain—Methotrexate—breast cancer	1.88e-05	0.000106	CcSEcCtD
Etoricoxib—Vomiting—Capecitabine—breast cancer	1.88e-05	0.000106	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Epirubicin—breast cancer	1.87e-05	0.000106	CcSEcCtD
Etoricoxib—Shock—Doxorubicin—breast cancer	1.87e-05	0.000106	CcSEcCtD
Etoricoxib—Nervous system disorder—Doxorubicin—breast cancer	1.87e-05	0.000105	CcSEcCtD
Etoricoxib—Thrombocytopenia—Doxorubicin—breast cancer	1.86e-05	0.000105	CcSEcCtD
Etoricoxib—Rash—Capecitabine—breast cancer	1.86e-05	0.000105	CcSEcCtD
Etoricoxib—Insomnia—Epirubicin—breast cancer	1.86e-05	0.000105	CcSEcCtD
Etoricoxib—Dermatitis—Capecitabine—breast cancer	1.86e-05	0.000105	CcSEcCtD
Etoricoxib—Headache—Capecitabine—breast cancer	1.85e-05	0.000104	CcSEcCtD
Etoricoxib—Skin disorder—Doxorubicin—breast cancer	1.85e-05	0.000104	CcSEcCtD
Etoricoxib—Dyspnoea—Epirubicin—breast cancer	1.83e-05	0.000103	CcSEcCtD
Etoricoxib—Somnolence—Epirubicin—breast cancer	1.83e-05	0.000103	CcSEcCtD
Etoricoxib—Anorexia—Doxorubicin—breast cancer	1.81e-05	0.000102	CcSEcCtD
Etoricoxib—Nausea—Docetaxel—breast cancer	1.81e-05	0.000102	CcSEcCtD
Etoricoxib—Feeling abnormal—Methotrexate—breast cancer	1.81e-05	0.000102	CcSEcCtD
Etoricoxib—Dyspepsia—Epirubicin—breast cancer	1.81e-05	0.000102	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Methotrexate—breast cancer	1.8e-05	0.000101	CcSEcCtD
Etoricoxib—Decreased appetite—Epirubicin—breast cancer	1.79e-05	0.000101	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Epirubicin—breast cancer	1.78e-05	0.0001	CcSEcCtD
Etoricoxib—Fatigue—Epirubicin—breast cancer	1.77e-05	0.0001	CcSEcCtD
Etoricoxib—Pain—Epirubicin—breast cancer	1.76e-05	9.92e-05	CcSEcCtD
Etoricoxib—Constipation—Epirubicin—breast cancer	1.76e-05	9.92e-05	CcSEcCtD
Etoricoxib—Nausea—Capecitabine—breast cancer	1.75e-05	9.89e-05	CcSEcCtD
Etoricoxib—Urticaria—Methotrexate—breast cancer	1.75e-05	9.85e-05	CcSEcCtD
Etoricoxib—Abdominal pain—Methotrexate—breast cancer	1.74e-05	9.8e-05	CcSEcCtD
Etoricoxib—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.73e-05	9.78e-05	CcSEcCtD
Etoricoxib—Insomnia—Doxorubicin—breast cancer	1.72e-05	9.71e-05	CcSEcCtD
Etoricoxib—Dyspnoea—Doxorubicin—breast cancer	1.7e-05	9.57e-05	CcSEcCtD
Etoricoxib—Feeling abnormal—Epirubicin—breast cancer	1.69e-05	9.56e-05	CcSEcCtD
Etoricoxib—Somnolence—Doxorubicin—breast cancer	1.69e-05	9.54e-05	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Epirubicin—breast cancer	1.68e-05	9.49e-05	CcSEcCtD
Etoricoxib—Dyspepsia—Doxorubicin—breast cancer	1.68e-05	9.45e-05	CcSEcCtD
Etoricoxib—Decreased appetite—Doxorubicin—breast cancer	1.65e-05	9.33e-05	CcSEcCtD
Etoricoxib—Gastrointestinal disorder—Doxorubicin—breast cancer	1.64e-05	9.27e-05	CcSEcCtD
Etoricoxib—Fatigue—Doxorubicin—breast cancer	1.64e-05	9.26e-05	CcSEcCtD
Etoricoxib—Urticaria—Epirubicin—breast cancer	1.63e-05	9.22e-05	CcSEcCtD
Etoricoxib—Pain—Doxorubicin—breast cancer	1.63e-05	9.18e-05	CcSEcCtD
Etoricoxib—Constipation—Doxorubicin—breast cancer	1.63e-05	9.18e-05	CcSEcCtD
Etoricoxib—Abdominal pain—Epirubicin—breast cancer	1.63e-05	9.17e-05	CcSEcCtD
Etoricoxib—Hypersensitivity—Methotrexate—breast cancer	1.62e-05	9.13e-05	CcSEcCtD
Etoricoxib—Asthenia—Methotrexate—breast cancer	1.58e-05	8.9e-05	CcSEcCtD
Etoricoxib—Feeling abnormal—Doxorubicin—breast cancer	1.57e-05	8.85e-05	CcSEcCtD
Etoricoxib—Gastrointestinal pain—Doxorubicin—breast cancer	1.56e-05	8.78e-05	CcSEcCtD
Etoricoxib—Pruritus—Methotrexate—breast cancer	1.56e-05	8.77e-05	CcSEcCtD
Etoricoxib—Hypersensitivity—Epirubicin—breast cancer	1.52e-05	8.55e-05	CcSEcCtD
Etoricoxib—Urticaria—Doxorubicin—breast cancer	1.51e-05	8.53e-05	CcSEcCtD
Etoricoxib—Abdominal pain—Doxorubicin—breast cancer	1.5e-05	8.49e-05	CcSEcCtD
Etoricoxib—Diarrhoea—Methotrexate—breast cancer	1.5e-05	8.48e-05	CcSEcCtD
Etoricoxib—Asthenia—Epirubicin—breast cancer	1.48e-05	8.32e-05	CcSEcCtD
Etoricoxib—Pruritus—Epirubicin—breast cancer	1.46e-05	8.21e-05	CcSEcCtD
Etoricoxib—Dizziness—Methotrexate—breast cancer	1.45e-05	8.2e-05	CcSEcCtD
Etoricoxib—Diarrhoea—Epirubicin—breast cancer	1.41e-05	7.94e-05	CcSEcCtD
Etoricoxib—Hypersensitivity—Doxorubicin—breast cancer	1.4e-05	7.91e-05	CcSEcCtD
Etoricoxib—Vomiting—Methotrexate—breast cancer	1.4e-05	7.88e-05	CcSEcCtD
Etoricoxib—Rash—Methotrexate—breast cancer	1.39e-05	7.82e-05	CcSEcCtD
Etoricoxib—Dermatitis—Methotrexate—breast cancer	1.38e-05	7.81e-05	CcSEcCtD
Etoricoxib—Headache—Methotrexate—breast cancer	1.38e-05	7.77e-05	CcSEcCtD
Etoricoxib—Asthenia—Doxorubicin—breast cancer	1.37e-05	7.7e-05	CcSEcCtD
Etoricoxib—Dizziness—Epirubicin—breast cancer	1.36e-05	7.67e-05	CcSEcCtD
Etoricoxib—Pruritus—Doxorubicin—breast cancer	1.35e-05	7.6e-05	CcSEcCtD
Etoricoxib—Vomiting—Epirubicin—breast cancer	1.31e-05	7.38e-05	CcSEcCtD
Etoricoxib—Nausea—Methotrexate—breast cancer	1.31e-05	7.36e-05	CcSEcCtD
Etoricoxib—Diarrhoea—Doxorubicin—breast cancer	1.3e-05	7.35e-05	CcSEcCtD
Etoricoxib—Rash—Epirubicin—breast cancer	1.3e-05	7.32e-05	CcSEcCtD
Etoricoxib—Dermatitis—Epirubicin—breast cancer	1.3e-05	7.31e-05	CcSEcCtD
Etoricoxib—Headache—Epirubicin—breast cancer	1.29e-05	7.27e-05	CcSEcCtD
Etoricoxib—Dizziness—Doxorubicin—breast cancer	1.26e-05	7.1e-05	CcSEcCtD
Etoricoxib—Nausea—Epirubicin—breast cancer	1.22e-05	6.89e-05	CcSEcCtD
Etoricoxib—Vomiting—Doxorubicin—breast cancer	1.21e-05	6.83e-05	CcSEcCtD
Etoricoxib—Rash—Doxorubicin—breast cancer	1.2e-05	6.77e-05	CcSEcCtD
Etoricoxib—Dermatitis—Doxorubicin—breast cancer	1.2e-05	6.76e-05	CcSEcCtD
Etoricoxib—Headache—Doxorubicin—breast cancer	1.19e-05	6.73e-05	CcSEcCtD
Etoricoxib—Nausea—Doxorubicin—breast cancer	1.13e-05	6.38e-05	CcSEcCtD
Etoricoxib—PTGS2—Disease—AKT2—breast cancer	2.42e-06	1.93e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—EGFR—breast cancer	2.42e-06	1.92e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—NOS3—breast cancer	2.41e-06	1.92e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.4e-06	1.91e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—NCOA2—breast cancer	2.4e-06	1.91e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—NCOA1—breast cancer	2.38e-06	1.9e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—COMT—breast cancer	2.37e-06	1.89e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GSTP1—breast cancer	2.36e-06	1.88e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—NCOA1—breast cancer	2.36e-06	1.88e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—STK11—breast cancer	2.35e-06	1.87e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CYP19A1—breast cancer	2.35e-06	1.87e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—PIK3CD—breast cancer	2.33e-06	1.85e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—HMOX1—breast cancer	2.33e-06	1.85e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CYP19A1—breast cancer	2.33e-06	1.85e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—STK11—breast cancer	2.33e-06	1.85e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.33e-06	1.85e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ITPR1—breast cancer	2.32e-06	1.85e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—FASN—breast cancer	2.32e-06	1.85e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—MED12—breast cancer	2.32e-06	1.84e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—DPYD—breast cancer	2.32e-06	1.84e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—BCHE—breast cancer	2.31e-06	1.84e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—SERPINE1—breast cancer	2.3e-06	1.83e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—CAV1—breast cancer	2.29e-06	1.83e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MDM2—breast cancer	2.29e-06	1.82e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—SLC5A5—breast cancer	2.29e-06	1.82e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—KRAS—breast cancer	2.28e-06	1.82e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ALDOA—breast cancer	2.28e-06	1.82e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—RAF1—breast cancer	2.28e-06	1.81e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—RELA—breast cancer	2.27e-06	1.81e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—ERBB2—breast cancer	2.26e-06	1.79e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ABCB1—breast cancer	2.24e-06	1.78e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PIK3CB—breast cancer	2.23e-06	1.77e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MTOR—breast cancer	2.23e-06	1.77e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PIK3CG—breast cancer	2.22e-06	1.77e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—NCOA3—breast cancer	2.22e-06	1.76e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—NQO1—breast cancer	2.21e-06	1.76e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—SLC2A1—breast cancer	2.21e-06	1.76e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—NOS3—breast cancer	2.2e-06	1.75e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—SLC2A2—breast cancer	2.2e-06	1.75e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—TYMS—breast cancer	2.2e-06	1.75e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.19e-06	1.74e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—COMT—breast cancer	2.18e-06	1.74e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GSTP1—breast cancer	2.17e-06	1.73e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PLA2G4A—breast cancer	2.17e-06	1.73e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—NCOR1—breast cancer	2.17e-06	1.73e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GSTM1—breast cancer	2.17e-06	1.73e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—COMT—breast cancer	2.16e-06	1.72e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.16e-06	1.72e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CPT1A—breast cancer	2.15e-06	1.71e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ABCG2—breast cancer	2.15e-06	1.71e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—MTR—breast cancer	2.15e-06	1.71e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GSTP1—breast cancer	2.15e-06	1.71e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CYP3A4—breast cancer	2.15e-06	1.71e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—HMOX1—breast cancer	2.14e-06	1.7e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.14e-06	1.7e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CXCL8—breast cancer	2.14e-06	1.7e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ITPR1—breast cancer	2.14e-06	1.7e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—HMOX1—breast cancer	2.12e-06	1.69e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ITPR1—breast cancer	2.12e-06	1.69e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CYP1B1—breast cancer	2.12e-06	1.68e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—HPGDS—breast cancer	2.11e-06	1.68e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—HBA1—breast cancer	2.1e-06	1.67e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—PIK3CA—breast cancer	2.1e-06	1.67e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PIK3CG—breast cancer	2.09e-06	1.66e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CDKN1B—breast cancer	2.09e-06	1.66e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—MDM2—breast cancer	2.09e-06	1.66e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—RAF1—breast cancer	2.08e-06	1.65e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—GPX1—breast cancer	2.08e-06	1.65e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—HSP90AA1—breast cancer	2.08e-06	1.65e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CYP1A1—breast cancer	2.06e-06	1.64e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—ERBB2—breast cancer	2.06e-06	1.64e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ABCB1—breast cancer	2.06e-06	1.64e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GSTT1—breast cancer	2.05e-06	1.63e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ACHE—breast cancer	2.05e-06	1.63e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CASP3—breast cancer	2.05e-06	1.63e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL2—breast cancer	2.04e-06	1.63e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ERCC2—breast cancer	2.04e-06	1.62e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ABCB1—breast cancer	2.04e-06	1.62e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—MTOR—breast cancer	2.03e-06	1.62e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—PIK3CB—breast cancer	2.03e-06	1.62e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CD4—breast cancer	2.03e-06	1.61e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—TYMS—breast cancer	2.02e-06	1.61e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—NCOA1—breast cancer	2.02e-06	1.61e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—TYMS—breast cancer	2e-06	1.59e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—NCOR1—breast cancer	2e-06	1.59e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GSTM1—breast cancer	2e-06	1.59e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PLA2G4A—breast cancer	2e-06	1.59e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CCND1—breast cancer	1.99e-06	1.59e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—STK11—breast cancer	1.99e-06	1.58e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CYP19A1—breast cancer	1.99e-06	1.58e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—JUN—breast cancer	1.99e-06	1.58e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GSTM1—breast cancer	1.98e-06	1.57e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—NCOR1—breast cancer	1.98e-06	1.57e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PLA2G4A—breast cancer	1.98e-06	1.57e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CTNNB1—breast cancer	1.97e-06	1.57e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PIK3CD—breast cancer	1.95e-06	1.55e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—HRAS—breast cancer	1.94e-06	1.54e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CYP17A1—breast cancer	1.94e-06	1.54e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MMP9—breast cancer	1.93e-06	1.54e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—CDKN1A—breast cancer	1.93e-06	1.53e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—ALB—breast cancer	1.93e-06	1.53e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PTEN—breast cancer	1.92e-06	1.53e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PTGS1—breast cancer	1.92e-06	1.53e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ENO1—breast cancer	1.92e-06	1.53e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—MTHFR—breast cancer	1.92e-06	1.53e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—GPX1—breast cancer	1.91e-06	1.52e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CDKN1B—breast cancer	1.91e-06	1.52e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—GPX1—breast cancer	1.9e-06	1.51e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CYP1A1—breast cancer	1.89e-06	1.51e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CYP2D6—breast cancer	1.88e-06	1.5e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MAPK8—breast cancer	1.88e-06	1.5e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ERCC2—breast cancer	1.88e-06	1.49e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CYP1A1—breast cancer	1.88e-06	1.49e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.87e-06	1.49e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ERCC2—breast cancer	1.86e-06	1.48e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—IL6—breast cancer	1.86e-06	1.48e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—COMT—breast cancer	1.85e-06	1.47e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—NCOA2—breast cancer	1.85e-06	1.47e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—NOS3—breast cancer	1.84e-06	1.47e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GSTP1—breast cancer	1.84e-06	1.46e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PIK3CD—breast cancer	1.84e-06	1.46e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—HMOX1—breast cancer	1.82e-06	1.44e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—ALB—breast cancer	1.81e-06	1.44e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ITPR1—breast cancer	1.81e-06	1.44e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CTNNB1—breast cancer	1.8e-06	1.43e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—FASN—breast cancer	1.79e-06	1.43e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—BCHE—breast cancer	1.79e-06	1.42e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—SRC—breast cancer	1.78e-06	1.42e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—CAV1—breast cancer	1.77e-06	1.41e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—MTHFR—breast cancer	1.76e-06	1.4e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—SLC5A5—breast cancer	1.76e-06	1.4e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—CDKN1A—breast cancer	1.76e-06	1.4e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—PTEN—breast cancer	1.75e-06	1.4e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—MTHFR—breast cancer	1.75e-06	1.39e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ABCB1—breast cancer	1.74e-06	1.39e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—VEGFA—breast cancer	1.74e-06	1.38e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—NOS3—breast cancer	1.73e-06	1.38e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—STAT3—breast cancer	1.72e-06	1.37e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Immune System—AKT1—breast cancer	1.71e-06	1.36e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—TYMS—breast cancer	1.71e-06	1.36e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Gene Expression—AKT1—breast cancer	1.71e-06	1.36e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—SLC2A1—breast cancer	1.7e-06	1.36e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—NQO1—breast cancer	1.7e-06	1.36e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PIK3CB—breast cancer	1.7e-06	1.35e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—NCOR1—breast cancer	1.69e-06	1.35e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PLA2G4A—breast cancer	1.69e-06	1.35e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GSTM1—breast cancer	1.69e-06	1.35e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.69e-06	1.35e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MAPK3—breast cancer	1.64e-06	1.31e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CYP1B1—breast cancer	1.63e-06	1.3e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—CAV1—breast cancer	1.63e-06	1.3e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—SRC—breast cancer	1.63e-06	1.29e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—GPX1—breast cancer	1.62e-06	1.29e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—CAV1—breast cancer	1.61e-06	1.28e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PIK3CG—breast cancer	1.61e-06	1.28e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CYP1A1—breast cancer	1.6e-06	1.28e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.6e-06	1.27e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PIK3CB—breast cancer	1.6e-06	1.27e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—MYC—breast cancer	1.6e-06	1.27e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TGFB1—breast cancer	1.59e-06	1.27e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ERCC2—breast cancer	1.59e-06	1.27e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PTGS2—breast cancer	1.59e-06	1.26e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—STAT3—breast cancer	1.57e-06	1.25e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—EGFR—breast cancer	1.56e-06	1.24e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—NCOA1—breast cancer	1.56e-06	1.24e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.54e-06	1.23e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CYP19A1—breast cancer	1.54e-06	1.22e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—STK11—breast cancer	1.54e-06	1.22e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—MAPK3—breast cancer	1.5e-06	1.19e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—MTHFR—breast cancer	1.5e-06	1.19e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PIK3CG—breast cancer	1.48e-06	1.18e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—KRAS—breast cancer	1.48e-06	1.18e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PIK3CG—breast cancer	1.47e-06	1.17e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PTEN—breast cancer	1.47e-06	1.17e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—MYC—breast cancer	1.46e-06	1.16e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—TGFB1—breast cancer	1.45e-06	1.16e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—COMT—breast cancer	1.43e-06	1.14e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—EGFR—breast cancer	1.43e-06	1.13e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GSTP1—breast cancer	1.42e-06	1.13e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PIK3CD—breast cancer	1.42e-06	1.13e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—HMOX1—breast cancer	1.4e-06	1.11e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—ALB—breast cancer	1.4e-06	1.11e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ITPR1—breast cancer	1.4e-06	1.11e-05	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PTEN—breast cancer	1.38e-06	1.1e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—CAV1—breast cancer	1.38e-06	1.1e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—PIK3CA—breast cancer	1.36e-06	1.08e-05	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—KRAS—breast cancer	1.35e-06	1.07e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ABCB1—breast cancer	1.34e-06	1.07e-05	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—NOS3—breast cancer	1.34e-06	1.06e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—TYMS—breast cancer	1.32e-06	1.05e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.32e-06	1.05e-05	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—TP53—breast cancer	1.31e-06	1.04e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—NCOR1—breast cancer	1.31e-06	1.04e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.31e-06	1.04e-05	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GSTM1—breast cancer	1.31e-06	1.04e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PIK3CD—breast cancer	1.3e-06	1.04e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PIK3CD—breast cancer	1.29e-06	1.03e-05	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—ALB—breast cancer	1.29e-06	1.02e-05	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—ALB—breast cancer	1.28e-06	1.01e-05	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PIK3CG—breast cancer	1.26e-06	9.99e-06	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—HRAS—breast cancer	1.26e-06	9.99e-06	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—GPX1—breast cancer	1.25e-06	9.95e-06	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—PIK3CA—breast cancer	1.24e-06	9.85e-06	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CYP1A1—breast cancer	1.24e-06	9.85e-06	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PIK3CB—breast cancer	1.24e-06	9.83e-06	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—NOS3—breast cancer	1.23e-06	9.79e-06	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ERCC2—breast cancer	1.23e-06	9.77e-06	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PTGS2—breast cancer	1.22e-06	9.74e-06	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—NOS3—breast cancer	1.22e-06	9.71e-06	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—IL6—breast cancer	1.2e-06	9.56e-06	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—MTHFR—breast cancer	1.15e-06	9.18e-06	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—HRAS—breast cancer	1.15e-06	9.11e-06	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PIK3CB—breast cancer	1.14e-06	9.04e-06	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PIK3CB—breast cancer	1.13e-06	8.96e-06	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PTGS2—breast cancer	1.13e-06	8.96e-06	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PTGS2—breast cancer	1.12e-06	8.88e-06	CbGpPWpGaD
Etoricoxib—MAPK14—Signaling Pathways—AKT1—breast cancer	1.11e-06	8.82e-06	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PIK3CD—breast cancer	1.1e-06	8.78e-06	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—IL6—breast cancer	1.1e-06	8.72e-06	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—ALB—breast cancer	1.09e-06	8.67e-06	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PTEN—breast cancer	1.07e-06	8.49e-06	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—CAV1—breast cancer	1.06e-06	8.47e-06	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—NOS3—breast cancer	1.04e-06	8.3e-06	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—PIK3CA—breast cancer	1.04e-06	8.25e-06	CbGpPWpGaD
Etoricoxib—PTGS2—Disease—AKT1—breast cancer	1.01e-06	8.05e-06	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PTEN—breast cancer	9.82e-07	7.81e-06	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—PIK3CA—breast cancer	9.76e-07	7.76e-06	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PTEN—breast cancer	9.73e-07	7.74e-06	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PIK3CG—breast cancer	9.69e-07	7.71e-06	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PIK3CB—breast cancer	9.62e-07	7.66e-06	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PTGS2—breast cancer	9.54e-07	7.59e-06	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PIK3CD—breast cancer	8.52e-07	6.78e-06	CbGpPWpGaD
Etoricoxib—PTGS2—Metabolism—AKT1—breast cancer	8.47e-07	6.74e-06	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—ALB—breast cancer	8.41e-07	6.69e-06	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PTEN—breast cancer	8.32e-07	6.62e-06	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—NOS3—breast cancer	8.05e-07	6.4e-06	CbGpPWpGaD
Etoricoxib—CYP2E1—Metabolism—AKT1—breast cancer	7.97e-07	6.34e-06	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—PIK3CA—breast cancer	7.53e-07	5.99e-06	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PIK3CB—breast cancer	7.43e-07	5.91e-06	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PTGS2—breast cancer	7.36e-07	5.86e-06	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—PIK3CA—breast cancer	6.93e-07	5.51e-06	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—PIK3CA—breast cancer	6.87e-07	5.46e-06	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PTEN—breast cancer	6.42e-07	5.11e-06	CbGpPWpGaD
Etoricoxib—CYP2C19—Metabolism—AKT1—breast cancer	6.15e-07	4.89e-06	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—PIK3CA—breast cancer	5.87e-07	4.67e-06	CbGpPWpGaD
Etoricoxib—CYP2D6—Metabolism—AKT1—breast cancer	5.66e-07	4.5e-06	CbGpPWpGaD
Etoricoxib—CYP2C9—Metabolism—AKT1—breast cancer	5.61e-07	4.46e-06	CbGpPWpGaD
Etoricoxib—CYP1A2—Metabolism—AKT1—breast cancer	4.79e-07	3.81e-06	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—PIK3CA—breast cancer	4.53e-07	3.6e-06	CbGpPWpGaD
Etoricoxib—CYP3A4—Metabolism—AKT1—breast cancer	3.7e-07	2.94e-06	CbGpPWpGaD
